COMPANY
|
|
FOR IMMEDIATE RELEASE
Contact:
Madalynne Chapman: (510) 608-5744 mchapman@velos.com
VELOS CARDIOLOGY AND CARDIOTHORACIC SURGERY, VERSION 2.0, COMPLETES CERTIFICATION FROM THE AMERICAN COLLEGE OF CARDIOLOGY (ACC)
Minneapolis, MN – May 1,
2001 – Velos, Inc. today announced that its Velos Cardiology and
Cardiothoracic Surgery information system has successfully concluded
certification by the American College of Cardiology (ACC) and is now
fully ACC Version 2.0 and Version 1.0 certified. Velos Cardiology
and Cardiothoracic Surgery is a scalable information system designed
to meet a range of customer needs in the cardiovascular
market.
“ACC 2.0 certification brings us into full compliance
with both the Society of Thoracic Surgeons (STS) and American
College of Cardiology (ACC) database specifications,” said Bob
Baumgartner, Sr. Product Manager, Velos Specialty Division. “The ACC
has made significant changes to their dataset to not only better
reflect current clinical practice but also allow for more fields to
be calculated, reducing data entry time. Velos’ customization tool,
dynamic warehouse, and development of critical reports allow the
user to integrate the wealth of data they are collecting to make
positive improvements in patient care and
operations.”
Recently, when asked why Velos Cardiology was
the ‘product of choice’, Ms. Julie Hallfrisch, R.N., who is the
Cardiac Registry Specialist at Benefis Healthcare in Montana,
replied, “Well, first, for any data that you present to a group of
physicians or insurance carriers, you want valid and reliable data.
With Velos, you know that the data is factual. Second would be the
efficiency of data entry. Time is money in any organization and the
less time you spend hitting keys, the better off we all
are.”
Reports are also important. Ms. Hallfrisch continued,
“The physicians want to know exactly how many procedures they are
performing a month; our surgeons want to know the length of stay
from procedure to discharge, what the predicted operative mortality
is for the cases we are doing; and how many patients we are seeing
with renal function deficits. That information is all right
there.”
About Velos
Velos is
a leading designer and developer of innovative healthcare
information systems. Velos provides an integrated clinical and
administrative product suite for specialty medicine and clinical
research. Velos markets its software solutions, together with system
integration and support services, to healthcare providers and
clinical trial sponsors. Velos is privately held with headquarters
in Silicon Valley.
This press release contains
forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially
from those set forth in the forward-looking statements. These
forward-looking statements represent Velos’ judgment as of the date
of this release. Actual results may differ materially from those
projected. Velos disclaims any intent or obligation to update these
forward-looking statements.
Information regarding the press
release may be obtained by contacting Madalynne Chapman
(510-608-5744 / mchapman@velos.com) or visiting
our website: www.velos.com
|
|
